Tennessee 114th General Assembly Status: Enacted Bipartisan · 2 R · 1 D cosponsors

HB 1239 — AN ACT to amend Tennessee Code Annotated, Title 33; Title 41; Title 53 and Title 63, relative to healthcare prescribers.

Last action — Effective date(s) 07/01/2025

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed House
  4. ✓
    Passed Senate
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced January 28, 2025. Enacted.

Signed by Governor Bill Lee (Republican) on April 10, 2025.

Prognosis

Likely to advance 92% · high confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Enacted

    Current position in the legislative process.

  • 3 sponsors

    1 primary, 2 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (2 R · 1 D) — cross-party backing.

  • Cleared a recorded vote

    Passed 2 recorded votes so far.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.

Bill Text

Action History

  1. Comp. became Pub. Ch. 295

  2. Pub. Ch. 295

  3. Effective date(s) 07/01/2025

  4. Signed by Governor.

  5. Transmitted to Governor for his action.

  6. Signed by Senate Speaker

  7. Signed by H. Speaker

  8. Enrolled; ready for sig. of H. Speaker.

  9. Companion House Bill substituted

  10. Sponsor(s) Added.

  11. H. adopted am. (Amendment 1 - HA0252)

  12. Sponsor(s) Added.

  13. Passed H., as am., Ayes 92, Nays 1, PNV 0

  14. Engrossed; ready for transmission to Sen.

  15. Received from House, Passed on First Consideration

  16. Senate substituted House Bill for companion Senate Bill.

  17. Amendment withdrawn. (Amendment 1 - SA0095)

  18. Passed Senate, Ayes 27, Nays 4

  19. Placed on Senate Regular Calendar for 4/7/2025

  20. Senate Reset on calendar for 4/7/2025

  21. H. Placed on Regular Calendar for 4/7/2025

  22. Placed on cal. Calendar & Rules Committee for 4/3/2025

  23. Placed on Senate Regular Calendar for 4/3/2025

  24. Rec. for pass. if am., ref. to Calendar & Rules Committee

  25. Senate Reset on calendar for 4/3/2025

  26. Sponsor(s) Added.

  27. Placed on Senate Regular Calendar for 3/31/2025

  28. Placed on cal. Health Committee for 4/1/2025

  29. Action def. in Health Committee to 4/1/2025

  30. Senate Reset on calendar for 3/31/2025

  31. Sponsor(s) Added.

  32. Placed on Senate Regular Calendar for 3/24/2025

  33. Rec for pass if am by s/c ref. to Health Committee

  34. Placed on cal. Health Committee for 3/25/2025

  35. Senate Reset on calendar for 3/27/2025

  36. Placed on Senate Regular Calendar for 3/17/2025

  37. Placed on s/c cal Health Subcommittee for 3/19/2025

  38. Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0

  39. Placed on Senate Judiciary Committee calendar for 3/11/2025

  40. Action deferred in Senate Judiciary Committee to 3/11/2025

  41. Placed on Senate Judiciary Committee calendar for 2/25/2025

  42. Passed on Second Consideration, refer to Senate Judiciary Committee

  43. P2C, ref. to Health Committee

  44. Assigned to s/c Health Subcommittee

  45. Introduced, Passed on First Consideration

  46. Intro., P1C.

  47. Filed for introduction

  48. Filed for introduction

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 2 co-sponsors · 130 not signed on

Sponsors (1)

Co-sponsors (2)

Not signed on (130)

130 members have not signed on to this bill.

Show all 130 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 1239 do?
Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.
Who sponsors HB 1239?
HB 1239 is sponsored by Helton-Haynes, Esther (Republican), Parkinson, Antonio (Democrat), and Alexander, Rebecca K. (Republican).
What is the current status of HB 1239?
This bill has been enacted into law. Introduced January 28, 2025. Enacted.
Where can I track HB 1239?
Track HB 1239 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 1239

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 1239

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →